Cargando…

Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer

BACKGROUND: Liquid biopsy has been proposed to be a promising noninvasive tool to obtain information on tumor progression. Through a clinical observation of a case series of 6 consecutive patients, we aim to determine the value of circulating tumor DNA (ctDNA) for monitoring the tumor burden during...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jiaolin, Chang, Lianpeng, Guan, Yanfang, Yang, Ling, Xia, Xuefeng, Cui, Liqiang, Yi, Xin, Lin, Guole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961398/ https://www.ncbi.nlm.nih.gov/pubmed/27459628 http://dx.doi.org/10.1371/journal.pone.0159708

Ejemplares similares

Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma
por: Wang, Dong, et al.
Publicado: (2020)

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer
por: Wang, Yan, et al.
Publicado: (2019)

Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients
por: Zhang, Yongliang, et al.
Publicado: (2021)

Author Correction: Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients
por: Zhang, Yongliang, et al.
Publicado: (2021)

Identification of circulating tumor DNA using a targeted 545-gene next generation sequencing panel in patients with gastric cancer
por: Lan, Jing, et al.
Publicado: (2020)

Recurrent Painful Perianal Subcutaneous Angiomatoid Fibrous Histiocytoma: A Case Report and Review of the Literature
por: Kong, Xiangyi, et al.
Publicado: (2014)

Clinicopathological and Molecular Characteristics of Colorectal Signet Ring Cell Carcinoma: A Review
por: An, Yang, et al.
Publicado: (2021)

Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer
por: Zhou, Yidong, et al.
Publicado: (2019)

Association of emergence of new mutations in circulating tumuor DNA during chemotherapy with clinical outcome in metastatic colorectal cancer
por: Jia, Ning, et al.
Publicado: (2021)

The feasibility of using mutation detection in ctDNA to assess tumor dynamics
por: Yi, Xin, et al.
Publicado: (2017)

Co‐mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancer
por: Xing, Puyuan, et al.
Publicado: (2019)

Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
por: Nong, Jingying, et al.
Publicado: (2018)

Analyzing microsatellite instability and gene mutation in circulating cell-free DNA to monitor colorectal cancer progression
por: Fu, Yun, et al.
Publicado: (2021)

Monitoring gastric cancer progression with circulating tumour DNA
por: Hamakawa, T, et al.
Publicado: (2015)

Circulating Tumor DNA: Less Invasive, More Representative Method to Unveil the Genomic Landscape of Newly Diagnosed Multiple Myeloma Than Bone Marrow Aspirates
por: Liu, Yang, et al.
Publicado: (2022)

Monitoring colorectal cancer following surgery using plasma circulating tumor DNA
por: Sun, Xiao, et al.
Publicado: (2018)

Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
por: Nong, Jingying, et al.
Publicado: (2019)

Circulating tumor DNA detection: A potential tool for colorectal cancer management
por: Li, Huizi, et al.
Publicado: (2019)

Blockade of Central GLP-1 Receptors Deteriorates the Improvement of Diabetes after Ileal Transposition
por: Chen, Weijie, et al.
Publicado: (2016)

Circulating tumor DNA applications in monitoring the treatment of metastatic colorectal cancer patients
por: Kazemifard, Nesa, et al.
Publicado: (2019)

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
por: Reece, Mifanwy, et al.
Publicado: (2019)

Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response
por: Jia, Ning, et al.
Publicado: (2019)

BC-Monitor: Towards a Routinely Accessible Circulating Tumor DNA-Based Tool for Real-Time Monitoring Breast Cancer Progression and Treatment Effectiveness
por: Priskin, Katalin, et al.
Publicado: (2021)

Genomic profiles and tumor immune microenvironment of primary lung carcinoma and brain oligo-metastasis
por: Song, Zhengbo, et al.
Publicado: (2021)

Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance
por: Hu, Zhe-Yu, et al.
Publicado: (2018)

Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression
por: Moss, Esther L., et al.
Publicado: (2020)

The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer
por: Feng, Yu, et al.
Publicado: (2022)

OTHR-07. CIRCULATING MIRNAS AS A NON-INVASIVE MONITORING TOOL FOR PEDIATRIC BRAIN TUMORS
por: Coyle, Anne, et al.
Publicado: (2023)

Seven DNA Methylation Biomarker Prediction Models for Monitoring the Malignant Progression From Advanced Adenoma to Colorectal Cancer
por: Wang, Wei, et al.
Publicado: (2022)

DNA methylation signatures in circulating cell-free DNA for the monitoring of at-risk populations progressing to lung cancer
por: Tost, Jörg
Publicado: (2015)

Treatment monitoring of colorectal cancer by integrated analysis of plasma concentration and sequencing of circulating tumor DNA
por: Yeh, Yu-Min, et al.
Publicado: (2020)

Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer
por: Lin, Wu-Hao, et al.
Publicado: (2021)

Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer
por: Yang, Jian, et al.
Publicado: (2020)

Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma
por: Hamana, K, et al.
Publicado: (2005)

Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma
por: Thomas, E, et al.
Publicado: (2005)

Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer
por: Egyud, Matthew, et al.
Publicado: (2018)

Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer
por: Jiang, Jiahong, et al.
Publicado: (2020)

Circulating biomarkers to monitor cancer progression and treatment
por: Rapisuwon, Suthee, et al.
Publicado: (2016)

Circulating Histones to Detect and Monitor the Progression of Cancer
por: Tsoneva, Desislava K., et al.
Publicado: (2023)

Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c2u77hho842vmckj9r7ujuneag